Immunization with non-replicating E. coli minicells delivering both protein antigen and DNA protects mice from lethal challenge with lymphocytic choriomeningitis virus
about
A highly optimized DNA vaccine confers complete protective immunity against high-dose lethal lymphocytic choriomeningitis virus challenge.Preclinical evaluation of VAX-IP, a novel bacterial minicell-based biopharmaceutical for nonmuscle invasive bladder cancer.A function of DivIVA in Listeria monocytogenes division site selection.
P2860
Immunization with non-replicating E. coli minicells delivering both protein antigen and DNA protects mice from lethal challenge with lymphocytic choriomeningitis virus
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Immunization with non-replicat ...... hocytic choriomeningitis virus
@ast
Immunization with non-replicat ...... hocytic choriomeningitis virus
@en
type
label
Immunization with non-replicat ...... hocytic choriomeningitis virus
@ast
Immunization with non-replicat ...... hocytic choriomeningitis virus
@en
prefLabel
Immunization with non-replicat ...... hocytic choriomeningitis virus
@ast
Immunization with non-replicat ...... hocytic choriomeningitis virus
@en
P2093
P2860
P1433
P1476
Immunization with non-replicat ...... hocytic choriomeningitis virus
@en
P2093
Kathleen L McGuire
Maria S Salvato
Matthew J Giacalone
Neil L Berkley
Roger A Sabbadini
Yen-Lin Chu
P2860
P304
P356
10.1016/J.VACCINE.2006.11.069
P407
P577
2006-12-26T00:00:00Z